Related Experiment Video
Updated: May 23, 2026
05:42
Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
Published on: January 3, 2020
Insulinoma in dogs: a review
Caroline M Goutal1, Bonnie L Brugmann, Kirk A Ryan
1Department of Veterinary Clinical Sciences, Louisiana State University Veterinary Teaching Hospital and Clinics, Baton Rouge, LA, USA.
Journal of the American Animal Hospital Association
|April 5, 2012
Summary
This review covers insulinomas, the most common pancreatic neuroendocrine tumor in dogs. It updates knowledge on diagnosing and treating these insulin-producing tumors and discusses their variable prognosis.
Area of Science:
- Veterinary Oncology
- Endocrinology
- Comparative Pathology
Background:
- Insulinomas are rare, malignant, functional pancreatic beta-cell tumors.
- They are the most common pancreatic neuroendocrine tumor in dogs.
- Clinical signs stem from hypoglycemia and associated neurological effects.
Purpose of the Study:
- To review and update current knowledge on canine insulinomas.
- To cover diagnosis, treatment, and prognosis.
- To synthesize classic information with recent trends.
Main Methods:
- Literature review of diagnostic and therapeutic strategies.
- Analysis of prognostic factors.
- Synthesis of current trends in management.
Main Results:
- Diagnosis and treatment of insulinomas are challenging.
- Prognosis is highly variable.
- Current trends focus on optimizing therapeutic choices.
Conclusions:
- Canine insulinomas require careful management due to complexity.
- Updated knowledge is crucial for improving patient outcomes.
- Further research may refine treatment protocols and prognostic indicators.
Related Concept Videos
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...